Search results for "DOPAMINERGIC"

showing 10 items of 200 documents

Therapeutic use of omega-3 fatty acids in bipolar disorder

2011

Bipolar disorder (BD) is a severe, chronic affective disorder, associated with significant disability, morbidity and premature mortality. Omega-3 polyunsaturated fatty acids (PUFAs) play several important roles in brain development and functioning. Evidence from animal models of dietary omega-3 (n-3) PUFA deficiency suggest that these fatty acids are relevant to promote brain development and to regulate behavioral and neurochemical aspects related to mood disorders, such as stress responses, depression and aggression, as well as dopaminergic content and function. Preclinical and clinical evidence suggests roles for PUFAs in BD. n-3 PUFAs seem to be an effective adjunctive treatment for unip…

chemistry.chemical_classificationBipolar Disordermedicine.drug_classBrain-Derived Neurotrophic FactorGeneral NeuroscienceDopaminergicMood stabilizerBioinformaticsmedicine.diseaseNeuroprotectionNeuroprotective AgentsNeurochemicalMood disorderschemistryFatty Acids Omega-3Adjunctive treatmentmedicineAnimalsHumansPharmacology (medical)Neurology (clinical)Bipolar disorderPsychologyClinical psychologyPolyunsaturated fatty acidExpert Review of Neurotherapeutics
researchProduct

Decision letter: Nitric oxide acts as a cotransmitter in a subset of dopaminergic neurons to diversify memory dynamics

2019

chemistry.chemical_compoundChemistryDopaminergicNeuroscienceNitric oxide
researchProduct

The role of the dopaminergic system in gratification processes.

2013

dopaminergic system gratification
researchProduct

Dopaminergic signaling in mouse duodenum and postanatal developmental changes

2012

dopaminergic trasmission postnatal enteric nervous system gut
researchProduct

Acetaldehyde as a drug of abuse: Involvement of endocannabinoid- and dopamine neurotransmission

2014

Acetaldehyde (ACD), the first metabolite of ethanol, directly enhances dopamine neurotransmission (1) and has rewarding and motivational properties in paradigms tailored for studying addictive-like behaviours (2, 3). The endocannabinoid system affects distinct drug-related behaviours, since it may in turn fine-tune dopamine cell activity (4, 5). In light of this, the present study aimed at investigating the effects of a direct manipulation of the DAergic synapse, and the contribution of the endocannabinoid system on oral ACD self-administration in rats. ACD drinking-behaviour was evaluated in an operant paradigm consisting of acquisition and maintenance; extinction; deprivation and relapse;…

endocannabinoid transmissionSettore BIO/14 - Farmacologiaoperant-conflict paradigmacetaldehydedopaminergic transmission
researchProduct

Pituitary resistance to thyroid hormone action with preserved circadian rhythm of thyrotropin in a postmenopausal woman.

1992

We assessed the 24-h behavior of circulating TSH and the dopaminergic control on TSH release in a postmenopausal woman, who had elevated levels of serum thyroid hormones and an inappropriately high concentration of serum TSH, indicating pituitary resistance to thyroid hormone action. The patient was found to have a daily profile of serum TSH similar to that of normal subjects, except for the persistently elevated 24 h levels, suggesting that alterations in thyroid hormone negative feedback control did not affect substantially circadian TSH rhythm. The acute administration of a dopamine antagonist drug (metoclopramide) resulted in a markedly elevated peak of serum TSH, similar both in the mo…

endocrine systemmedicine.medical_specialtyThyroid Hormonesendocrine system diseasesEndocrinology Diabetes and MetabolismDrug ResistanceThyrotropinThyroid Function TestsThyroid function testsHyperthyroidismEndocrinologyTRH stimulation testInternal medicinemedicineHumansCircadian rhythmmedicine.diagnostic_testbusiness.industryThyroidDopaminergicDopamine antagonistMiddle AgedBromocriptineCircadian Rhythmmedicine.anatomical_structureEndocrinologyPituitary GlandFemaleMenopausebusinesshormones hormone substitutes and hormone antagonistsHormonemedicine.drugJournal of endocrinological investigation
researchProduct

Evaluación estandarizada del potencial antiangiógénico del agonista dopaminérgico en el tratamiento de la endometriosis

2018

La endometriosis es una enfermedad crónica, de elevada prevalencia y etiopatogenia no claramente establecida, para la que no se dispone, actualmente, de un tratamiento seguro y eficaz a largo plazo. El establecimiento de la angiogénesis como uno de los requisitos fundamentales en la implantación y desarrollo de la enfermedad ha llevado a considerar los fármacos antiangiogénicos como una potencial diana terapéutica. Estos compuestos han demostrado, en modelos animales, reducir el tamaño de las lesiones endometriales; sin embargo, el uso de estos compuestos en humanos se ve limitado por el intolerable perfil de efectos secundarios que presenta. Los agonistas dopaminérgicos (fármacos con un pe…

endometriosisantiangiogénicos y endometriosisangiogénesis y agonistas dopaminérgicosangiogénesis y endometriosisagonistas dopaminergicosUNESCO::CIENCIAS MÉDICAS ::Ciencias clínicas::Ginecologíatratamiento endometriosis:CIENCIAS MÉDICAS ::Ciencias clínicas::Ginecología [UNESCO]cabergolina
researchProduct

DA-Phen, a new dopamine aminoacid conjugate: in vivo testing and molecular modeling as dopaminergic modulator

2014

in vivo testingDopaminergic modulatormolecular modelingSettore CHIM/09 - Farmaceutico Tecnologico ApplicativoSettore BIO/14 - FarmacologiaSettore CHIM/08 - Chimica Farmaceuticaaminoacid conjiugate
researchProduct

Structure-activity relationship of dopaminergic halogenated 1-benzyl-tetrahydroisoquinoline derivatives

2009

Two series of halogenated 1-benzyl-7-chloro-6-hydroxy-tetrahydroisoquinolines were prepared to explore the influence of each series on the affinity for dopamine receptors. All the compounds displayed a high affinity for D(1)-like and/or D(2)-like dopamine receptors in striatal membranes, although they were unable to inhibit [(3)H]-dopamine uptake in striatal synaptosomes. The halogen placed on the benzylic ring in 1-benzyl-THIQs, compounds of the series 1, 2'-bromobenzyl derivatives with K(i) values into the nanomolar range, and the series 2, 2',4'-dichlorobenzyl-THIQ homologues, proves to be an important factor to modulate affinity at dopamine receptor. (C) 2009 Elsevier Masson SAS. All ri…

inorganic chemicalsHalogenationStereochemistryChemical synthesisReceptors DopamineStructure-Activity Relationshipchemistry.chemical_compoundStructure–activity relationshipsDopamineTetrahydroisoquinolinesBiogenic amineDrug DiscoverymedicineAnimalsStructure–activity relationshipRats WistarNeurotransmitterDopamine receptorsSTRUCTURE-ACTIVITY RELATIONSHIPSPharmacologychemistry.chemical_classification1-Halogenated benzyl-7-chloro-6-hydroxy-tetrahydroisoquinolinesDopamine uptakReceptors Dopamine D2Receptors Dopamine D1Otras Ciencias QuímicasOrganic ChemistryDopaminergicCiencias QuímicasGeneral MedicineBinding1-Halogenated benzyl-7-chloro-6-hydroxytetrahydroisoquinolinesRatschemistryDopamine receptorDOPAMINE UPTAKECatecholamineFemaleCIENCIAS NATURALES Y EXACTASProtein Bindingmedicine.drug
researchProduct

Dopamine Related Genes Differentially Affect Declarative Long-Term Memory in Healthy Humans

2020

In humans, monetary reward can promote behavioral performance including response times, accuracy, and subsequent recognition memory. Recent studies have shown that the dopaminergic system plays an essential role here, but the link to interindividual differences remains unclear. To further investigate this issue, we focused on previously described polymorphisms of genes affecting dopaminergic neurotransmission: DAT1 40 base pair (bp), DAT1 30 bp, DRD4 48 bp, and cannabinoid receptor type 1 (CNR1). Specifically, 669 healthy humans participated in a delayed recognition memory paradigm on two consecutive days. On the first day, male vs. female faces served as cues predicting an immediate moneta…

long-term memory ; motivation ; polymorphism ; reward ; dopamineCognitive NeuroscienceBiologyAffect (psychology)lcsh:RC321-571polymorphism03 medical and health sciencesBehavioral Neurosciencelong-term memory0302 clinical medicinemotivationDopamineNeuromodulationmedicineAllelelcsh:Neurosciences. Biological psychiatry. NeuropsychiatryrewardOriginal Research030304 developmental biologyRecognition memory0303 health sciencesRecallLong-term memoryDopaminergicNeuropsychology and Physiological Psychologymedicine.anatomical_structuredopamineNeuroscience030217 neurology & neurosurgerymedicine.drugFrontiers in Behavioral Neuroscience
researchProduct